๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT06664983Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
84
Guangzhou
2024-10-21
Recruiting
Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL
NCT06651853Diffuse Large B-cell Lymphoma, Relapsed and Refractory
The First Affiliated Hospital of Xiamen University
Phase 2
22
Xiamen
2024-10-21
Active, closed
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
NCT06551324Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer
Phase 3
600
Wuhu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Guilin, Wuhan
2024-10-21
Recruiting
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT06649331Advanced Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer (TNBC), HER2-negative Breast Cancer
Fudan University
Phase 2
160
Shanghai
2024-10-21
Recruiting
Opioid-free Anesthesia Protocol for Neurosurgical Supratentorial Tumor Resection
NCT06607029Supratentorial Tumors
Beijing Tiantan Hospital
Not applicable
170
Beijing
2024-10-21
Recruiting
A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers
NCT06611345Biliary Tract Cancers (BTC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Not applicable
60
Hefei
2024-10-21
Active, closed
A Clinical Trial With KJ103 in Anti-GBM Disease
NCT06607016Anti-Glomerular Basement Membrane Disease
Shanghai Bao Pharmaceuticals Co., Ltd.
Phase 2
12
Beijing
2024-10-21
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
NCT06633341T-lymphoblastic Lymphoma
Zhejiang University
Phase EARLY_PHASE1
30
Hangzhou
2024-10-20
By invitation
Health Behavior Management Program for Patients With Coronary Heart Disease
NCT07330882Coronary Disease
The First Affiliated Hospital of Bengbu Medical University
Not applicable
200
Bengbu
2024-10-20
Recruiting
AI-Driven CTA Reconstruction for Intracranial LVO
NCT06645405Acute Ischemic Stroke, Artificial Intelligence (AI), Endovascular Thrombectomy, CT Angiography
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
174
Shanghai
2024-10-20
Active, closed
An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy
NCT06288230Spinal Muscular Atrophy
Lantu Biopharma
Phase 1/2
20
Kunming
2024-10-20
Recruiting
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
NCT06642948Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase Inhibitors
Fudan University
Not applicable
80
Shanghai
2024-10-20
Not yet open
Phase IIT Trial of SNA014
NCT06646783Adenocarcinoma of the Stomach, Adenocarcinoma of GE Junction, Pancreatic Cancer Stage
SmartNuclide Biopharma
Phase EARLY_PHASE1
28
Jiangsu
2024-10-20
Recruiting
Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma
NCT07202156Melasma (Facial Melasma)
The First Affiliated Hospital with Nanjing Medical University
Not applicable
35
Nanjing
2024-10-20
Active, closed
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
NCT06591520Biliary Tract Cancer
Akeso
Phase 3
682
Harbin, Shanghai
2024-10-20
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
NCT06640582Brain Tumor, Brain Metastases, Brain Cancer, Glioma
Essen Biotech
Phase 1/2
85
Beijing
2024-10-20
Recruiting
Neoadjuvant Therapy in Cervical Cancer
NCT06558682Uterine Cervical Neoplasms
Qilu Hospital of Shandong University
Not applicable
48
Jinan
2024-10-20
Not yet open
Effects of Sleep Body Temperature on Body Composition
NCT06648109Blood Pressure Check (Hypertension Screening), Heart Rate, Aldosterone Disorder
Jinan University Guangzhou
Not applicable
40
Guangzhou
2024-10-20
By invitation
Clinical Classification and Imaging Markers in Patients of Obesity
NCT06649071Obesity, fMRI, Clinical Classification
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
100
Nanjing
2024-10-20
Not yet open
Current Survey on Chemotherapy-Related Myelosuppression and Clinical Management in Chinese County-level Tumor Patients
NCT06641934Myelosuppression
The First Affiliated Hospital of Xinxiang Medical College
Observational
1,000
Xinxiang
2024-10-20
Recruiting
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
NCT06633328Aplastic Anemia
Zhejiang University
Phase EARLY_PHASE1
30
Hanzhou
2024-10-20
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
NCT06633354T-Acute Lymphoblastic Leukemia
Zhejiang University
Phase EARLY_PHASE1
30
Hangzhou
2024-10-20
Not yet open
The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy
NCT06614985Primary Membranous Nephropathy
Renmin Hospital of Wuhan University
Phase 2
172
Wuhan
2024-10-20
Recruiting
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT06554301Pulmonary Arterial Hypertension
China National Center for Cardiovascular Diseases
Phase 1
72
Beijing
2024-10-20
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
NCT06644274Gastrointestinal Malignancies
Ruijin Hospital
Observational
40
Shanghai
2024-10-20
Recruiting
Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract
NCT05439135Malnutrition, Gastroenterostomy
The Second Hospital of Nanjing Medical University
Not applicable
62
Nanjing
2024-10-20
Not yet open
Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
NCT06632522Liver Cancer
Beijing Tsinghua Chang Gung Hospital
Phase 2
46
Beijing
2024-10-20
Recruiting
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
NCT06458257Acute Myeloid Leukemia
Ruijin Hospital
Observational
50
Shanghai
2024-10-19
Not yet open
"Eye" Education for Parents and Myopia Control in Children
NCT06652594Children, Health Education, Anxiety
Beijing Tongren Hospital
Not applicable
498
Beijing
2024-10-19
Recruiting
Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy
NCT06601621Electroacupuncture, Quality of Life (QOL), Acupressure, Breast Cancer
Jiuda Zhao
Not applicable
192
Xining
2024-10-19
Recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
NCT06544499Primary Immune Thrombocytopenia (ITP)
argenx
Phase 3
69
Beijing, Bengbu, Chengde, Hohhot, Huai'an, Huizhou, Tianjin, Wuhan
2024-10-18
Recruiting
Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer
NCT06642428Vitamin D, Neoadjuvant Therapy, Breast Cancer, Adverse Reaction
Jiuda Zhao
Not applicable
140
Xining
2024-10-18
Active, closed
A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults
NCT06494527Safety Issues
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.
Phase 1
30
Beijing
2024-10-18
Recruiting
A Phase โ…ก Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
NCT06782594Postoperative Gastrointestinal Dysfunction
Shandong New Time Pharmaceutical Co., LTD
Phase 2
150
Feixian, Wuhan
2024-10-18
Recruiting
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
NCT06090994Colorectal Cancer
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Recruiting
PRospective Observation on CErebral microvaScular Structure and Function
NCT06579677Cerebral Microvascular Dysfunction, Cerebral Small Vessel Diseases, Cognitive Dysfunction, Cerebrovascular Disorders
Beijing Tiantan Hospital
Observational
3,500
Beijing
2024-10-18
Recruiting
The Impact of Soft Contact Lenses on the Corneal Neuromediators and Optical Quality in High Myopia Prior to SMILE
NCT06650306Contact Lens Complication
yuhao shao
Observational
80
Shanghai
2024-10-18
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06662786Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
1,000
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Harbin, Huizhou, Nanchang
2024-10-18
Recruiting
Correlation Analysis of POD and pNCD in Elderly Patients With Gastrointestinal Neoplasms
NCT06466096Postoperative Delirium, Postoperative Neurocognitive Disorder, Gastrointestinal Surgery
Xuanwu Hospital, Beijing
Observational
165
Beijing
2024-10-18
Active, closed
Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation
NCT06780930Residual or Recurrent Grade 2 IDH Mutant Glioma
Servier
Phase 3
57
Shenzhen, Chengdu, Beijing, Shanghai, Xi'an
2024-10-18
Recruiting
Application of CIELab Spectrophotometry to Analyze Gingival Color: a New Perspective for Evaluating the Effectiveness of Periodontal Basic Treatment
NCT06698718Periodontitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
30
Hangzhou
2024-10-18
Recruiting
Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis
NCT06899399Asymptomatic Carotid Artery Stenosis
Beijing Tiantan Hospital
Not applicable
982
Beijing
2024-10-18
Recruiting
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors
NCT06598800Advanced Solid Tumor
BeOne Medicines
Phase 1
153
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Shijiazhuang, Harbin, Wuhan
2024-10-18
Recruiting
A Study to Evaluate the Diagnostic Efficacy of 68Ga- MY6349 PET/CT in Patients With Tumours
NCT06770478Tumour of Epithelial Origin, 68Ga-MY6349
Xijing Hospital
Not applicable
40
Xi'an
2024-10-18
Recruiting
Study on Topping-off Technique for Treating LDD
NCT06650046Lumbar Degenerative Disease
Qianfoshan Hospital
Not applicable
100
Jinan
2024-10-18
Active, closed
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
NCT06643481Amyotrophic Lateral Sclerosis (ALS)
Novartis Pharmaceuticals
Phase 2
251
Beijing
2024-10-17
Recruiting
Application of Platelet-rich Plasma (PRP) in Reproductive Medicine
NCT06645379Premature Ovarian Insufficiency, Intrauterine Adhesion, Poor Ovarian Response, Repeated Implantation Failure
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
300
Yiwu
2024-10-17
Recruiting
A Study of BL-B01D1 in Patients With Recurrent Glioblastoma
NCT06598787Recurrent Glioblastoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
20
Beijing
2024-10-17
Recruiting
Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
NCT06742515Precursor B-Cell Acute Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University
Phase 2
20
Hangzhou
2024-10-17
Recruiting
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
NCT06604117Ischemic Stroke, Atherosclerosis of Artery, Lipid Disorder, Statin
Xuanwu Hospital, Beijing
Observational
200
Xicheng District
2024-10-17
Recruiting
The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line Treatment of HER2 Positive Metastatic Breast Cancer
NCT06641544Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 4
200
Shanwei
2024-10-17
Active, closed
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
NCT06640049Neoplasms, Rectal
GlaxoSmithKline
Phase 2
23
Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Kunming, Shanghai
2024-10-17
Recruiting
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours
NCT06695689Solid Tumor
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1
10
Tianjin
2024-10-17
Recruiting
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
NCT06515314Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd.
Phase 1
12
Shanghai
2024-10-17
Active, closed
Mass Balance Clinical Trial of SIM0270
NCT06654791Healthy Participants
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
6
Jinan
2024-10-17
Active, closed
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
NCT07274761Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
24
Shanghai
2024-10-17
Recruiting
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
NCT06730373HER2-positive Gastric Cancer, Metastatic Gastric Cancer, Unresectable Gastric Carcinoma
Qilu Hospital of Shandong University
Phase 2
110
Zhengzhou, Binzhou, Dongying, Jinan, Jining, Liaocheng, Linyi, Qingdao
2024-10-17
Recruiting
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
NCT06585514Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Beijing GoBroad Hospital
Phase 1/2
18
Beijing
2024-10-17
Recruiting
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors
NCT06612840Non-small Cell Lung Cancer, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Shanghai
2024-10-16
Recruiting
Effects of High-Intensity Interval Training on Bone Health in Hong Kong Older Women
NCT06888544Osteopenia
Hong Kong Baptist University
Not applicable
48
China
2024-10-16
Recruiting
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
NCT06572267Coronary Artery Disease
Xijing Hospital
Phase 2
18
Xi'an
2024-10-16
Recruiting
Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT06802666Locally Advanced Rectal Cancer, Neoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
45
Hubei
2024-10-16
Recruiting
Acute Effects of Cold Exposure on Cardiovascular System
NCT06652425Cardiovascular System
Fudan University
Not applicable
40
Shanghai
2024-10-16
Active, closed
Acute Effects of Low Temperature Exposure on Respiratory System
NCT06652932Lung Function
Fudan University
Not applicable
40
Shanghai
2024-10-16
Not yet open
An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis
NCT06645197Amyotrophic Lateral Sclerosis (ALS)
Peking University Third Hospital
Phase EARLY_PHASE1
7
Beijing, Fujian, Nanjing, Chengdu, Hangzhou
2024-10-16
Active, closed
Acute Effects of Cold Exposure on Cognitive Function
NCT06654167Cognitive Function
Fudan University
Not applicable
40
Shanghai
2024-10-16
Active, closed
Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer
NCT06766019Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2
47
Nanjing
2024-10-16
Recruiting
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
NCT06539624Fabry Disease
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
12
Shanghai, Hangzhou
2024-10-16
Recruiting
DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
NCT06353126Liver Cancer
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Recruiting
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
NCT06760273Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China
Observational
364
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shenzhen, Zhanjiang, Nanning
2024-10-16
Recruiting
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
NCT06589089Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
18
Shanghai
2024-10-15
Recruiting
WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma
NCT05925764Lung Adenocarcinoma, Whole Slide Image, IASLC Grading System, Artificial Intelligence
Shanghai Pulmonary Hospital, Shanghai, China
Observational
200
Zunyi, Nanchang, Ningbo
2024-10-15
Recruiting
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
NCT06241482Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease, Moderate or Severe Coma
Shanghai 6th People's Hospital
Not applicable
80
Shanghai
2024-10-15
Recruiting
Safety and Effectiveness Evaluation of Spinal Laminectomy Robot
NCT06593574Lumbar Spinal Stenosis, Lumbar Disc Herniation
Peking University Third Hospital
Not applicable
70
Beijing, Guangzhou, Hangzhou
2024-10-15
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
NCT06644287Advanced Soft Tissue Sarcomas
Ruijin Hospital
Observational
40
Shanghai
2024-10-15
By invitation
A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiation Proctitis
NCT06974123Safety
The First Affiliated Hospital of Xinxiang Medical College
Phase 1/2
29
Xinxiang
2024-10-15
Active, closed
MRD in PAAD Adjuvant Therapy
NCT06867146The Role of Molecular Residual Disease in the Treatment Strategy and Prognosis Prediction of Pancreatic Cancer Patients Undergoing Adjuvant Therapy, Molecular Residual Disease, Pancreatic Cancer, Adjuvant Therapy
Peking Union Medical College Hospital
Not applicable
60
Beijing
2024-10-15
Recruiting
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
NCT06743568Aortic Stenosis, Ascending Aortic Dilatation
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing, Shenzhen, Kunming
2024-10-15
Recruiting
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
NCT06664996Hepatocellular Carcinoma (HCC)
West China Hospital
Phase 2
33
Chengdu
2024-10-15
Recruiting
Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage โ…ก-โ…ข Non-small Cell Lung Cancer: A Phase โ…ข, Randomized, Multicenter, Prospective Study
NCT06598527Lung Cancer (NSCLC)
Yang Hong
Phase 3
360
Guangzhou
2024-10-15
Not yet open
Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
NCT06645210Allergic Bronchopulmonary Aspergillosis
Peking University Third Hospital
Observational
300
Beijing
2024-10-15
Recruiting
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
NCT07031661High-risk, Bipolar Disorder, Atypical Depression
Shanghai Mental Health Center
Observational
1,200
Shanghai
2024-10-15
Not yet open
Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)
NCT06658561Cold Snare Resection, Hot Snare Resection, Polyps of Colon
Ruijin Hospital
Not applicable
982
Shanghai
2024-10-15
Recruiting
Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.
NCT06860763Acupuncture, ADHD - Attention Deficit Disorder With Hyperactivity, Children, Interview
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Not applicable
120
Beijing
2024-10-15
By invitation
Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Colorectal Cancer Surgery
NCT06636864Laparoscopic Colorectal Cancer Surgery
Sun Yat-sen University
Not applicable
252
Guangzhou
2024-10-15
Not yet open
Neoadjuvant With Tฮฑ1 Plus Immuno-chemotherapy for Resectable NSCLC
NCT06607926Resectable Non-Small-Cell Lung Cancer
Xuanwu Hospital, Beijing
Not applicable
40
Beijing
2024-10-15
Recruiting
Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury
NCT07232277Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury
Zhuan Zhang
Observational
114
Yangzhou
2024-10-15
Recruiting
Study of IBI363 in Patients with Advanced First-line Gastric Cancer
NCT06610799IBI363 + Chemotherapy
Xiangdong Cheng
Phase 1
40
Hangzhou
2024-10-15
Recruiting
Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
NCT07115082Premature Ovarian Insufficiency
Yan Hongli
Phase 1/2
50
Shanghai
2024-10-15
By invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
NCT06876675Non-Small Cell Lung Cancer, Hyperlipidemia
Peking University Third Hospital
Observational
167
Beijing
2024-10-15
Recruiting
Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.
NCT06660511Ovarian Cancer Recurrent
Second Xiangya Hospital of Central South University
Phase EARLY_PHASE1
5
Changsha
2024-10-15
Recruiting
HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
NCT06709885Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2
100
Chongqing
2024-10-15
Not yet open
Efficacy and Safety of Electroacupuncture on Lumbar Disc Herniation with Radiculopathy
NCT06611332Lumbar Disc Herniation, Radiculopathy Lumbar
Jiangxi University of Traditional Chinese Medicine
Not applicable
170
Jiangxi
2024-10-15
Active, closed
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
NCT06629818Light Chain (AL) Amyloidosis
Peking Union Medical College Hospital
Phase 2
36
Beijing
2024-10-15
Recruiting
Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
NCT07010523Mesothelin-positive Advanced Malignant Solid Tumors
First Affiliated Hospital of Zhejiang University
Not applicable
24
Hangzhou
2024-10-15
Not yet open
Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
NCT06607081Degenerative Spinal Disease, Elderly Patients, Spinal Fusion Acquired
Xijing Hospital
Not applicable
5,000
Xi'an
2024-10-15
Not yet open
To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia
NCT06622824Androgenetic Alopecia (AGA)
Suzhou Kintor Pharmaceutical Inc,
Phase 2/3
756
Beijing
2024-10-15
Recruiting
Intelligent Segmentation Algorithm of Ultrasonic Image
NCT06646679Segmentation
Tongji Hospital
Observational
5,000
Wuhan
2024-10-14
Active, closed
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
NCT06827145Non-Small-Cell Lung Cancer
National Cancer Center, China
Phase 2
30
Beijing
2024-10-14
Not yet open
Phimumeยฎ Percutaneous Left Ventricular Assist System Study
NCT06639321Coronary Artery Disease
Shanghai NewMed Medical Co., Ltd.
Not applicable
250
Jilin City, Chengdu, Zhengzhou, Wuhan, Changsha, Shenyang
2024-10-14
Rows per page Showing 11101–11200 of 19052
Previous 110 111 112 113 114 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=112

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.